Le Lézard
Classified in: Health
Subjects: PDT, MAT

CBx Sciences Botanical Vapes Now Available in Colorado


DENVER, Feb. 21, 2018 /PRNewswire/ -- CBx Sciences today announced the availability of its Amplify and Meditate Vapes in Colorado. Initially launching with two formulations, the vapes feature thoughtfully selected botanical infusions such as ginseng and passionflower, combined with a wide variety of cannabinoids extracted with Evolab's award-winning CO2 technology.

"While there are plenty of vape pens competing to achieve the highest THC potency, it's critical to recognize that other cannabinoids and a full spectrum of terpenes are essential to activating the various receptors that comprise the Endocannabinoid System," said Nicole Smith, CEO, CBx Sciences. "Our new vapes utilize Evolab's advanced extraction technology so that we can include the greatest variety of cannabinoids and cannabis terpenes, then we infuse other proven plant ingredients to maximize effect and flavor."

From Green Tea extract for energy to Passion Flower for meditation and release, each formula is designed to augment and amplify the effects of full spectrum cannabis extracts, elevating the experience and benefits. Like all Evolab and CBx products, the new Vapes use a proprietary 'Cannabis Derived Cutting Agent' and never contain residual solvents or any other chemical additives.

CBx Sciences products are available in dispensaries across Colorado. To find the location nearest you, visit our Store Locator. Stay tuned for additional CBx Sciences products and news in the coming months.

About CBx Sciences:

CBx Sciences is an international botanical technology company. Founded by a team of seasoned experts, the company is dedicated to advancing the global cannabis industry by creating effective products, formulations and technology platforms that support and replenish the Endocannabinoid System. CBx Sciences holds distribution, licensing and intellectual property agreements with a number of leading cannabis and healthcare brands including Evolab. Learn more at CBxSciences.com

Supporting Resources:

Follow @CBxSciences on:

Follow @evolabco2 on:                                                                                                                                                                                                                     

 

SOURCE Evolab


These press releases may also interest you

at 06:50
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZtm (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis...

at 06:08
The Annual General Meeting of Bioretec Ltd was held on 26 April 2024 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January?31 December 2023 and resolved to discharge the members of the...

at 06:00
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...



News published on and distributed by: